Literature DB >> 24047563

The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.

Kyung-Soo Kim1, Hyun-Ju Oh, Dae-Jung Kim, Soo-Kyung Kim, Seok Won Park, Yong-Wook Cho, Kap-Bum Huh.   

Abstract

Our aim was to investigate whether the evaluation of non-alcoholic fatty liver disease (NAFLD) by ultrasound provides additional benefit in assessing carotid atherosclerotic burden in subjects with alanine aminotransferase (ALT) concentrations within the reference range. This was a cross-sectional analysis of 769 healthy individuals (326 men and 443 women) with an ALT concentration ≤ 40 IU/L and alcohol consumption < 140 g/week. Mean carotid artery intima-media thickness (C-IMT) was measured using ultrasound. NAFLD was defined as a mild or greater degree of hepatic steatosis on ultrasound. Although all subjects had an ALT concentration within the reference range, the prevalence of NAFLD increased with increasing quartiles of ALT concentration (27.1%, 40.0%, 54.7%, 75.3% in men, P for trend < 0.001; 22.0%, 34.4%, 35.7%, 55.0% in women, P for trend < 0.001). In the 3rd and 4th quartiles of ALT concentration, women with NAFLD had a significantly higher C-IMT than those without NAFLD (0.671±0.019 mm vs. 0.742±0.025 mm, P=0.023 in Q3; 0.651±0.023 mm vs. 0.737±0.021 mm, P=0.005 in Q4). These differences remained significant even after adjusting for a broad spectrum of potential confounders. In contrast, although men with NAFLD tended to have a higher C-IMT than those without NAFLD in each quartile, these differences were not statistically significant. Women with an upper normal range ALT concentration showed increased C-IMT only when they had NAFLD. Therefore, in women with an elevated ALT level within the reference range, further evaluation for NAFLD, such as liver ultrasound, could potentially identify those patients at high risk for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24047563     DOI: 10.1507/endocrj.ej13-0269

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

Review 1.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

2.  Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity.

Authors:  Glenn S Gerhard; Peter Benotti; G Craig Wood; Xin Chu; George Argyropoulos; Anthony Petrick; William E Strodel; Jon D Gabrielsen; Anna Ibele; Christopher D Still; Christopher Kingsley; Johanna DiStefano
Journal:  J Obes       Date:  2014-12-24

3.  Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients.

Authors:  Lei Zhang; Kaifeng Guo; Junxi Lu; Fangya Zhao; Haoyong Yu; Junfeng Han; Yuqian Bao; Haibing Chen; Weiping Jia
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

Review 4.  Non-alcoholic fatty liver disease-From the cardiologist perspective.

Authors:  Oana Sîrbu; Mariana Floria; Petru Dăscălița; Victorița Şorodoc; Laurențiu Şorodoc
Journal:  Anatol J Cardiol       Date:  2016-07       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.